The Midterm Campaign Will Be 'America Is Awesome vs. America Is Awful'
Why Karoline Leavitt Ripped Into CNN's Kaitlin Collins Yesterday
PLATT-inum Deal: We're Getting Oil and Gold From Venezuela Now
Did the Lizard People Write This? WaPo's Editorial on the DHS Shutdown Is...
The Crazed Man Who Went on a Stabbing Spree on I-495 in VA...
Yeah, About Those Dancing Frogs at the Dems' Alternate SOTU Circus
Legal Expert Calls Spanberger's Judicial Warrant Demand Unreasonable, Unnecessary
It Looks Like an Iranian Drones Hit Azerbaijan
The War Department Has Released the Names of Two Additional Heroes Killed in...
Why the United States Must Keep Funding Israel’s Defense
The Clintons: At It Again
The Iranian Two-Step
Epic Fury: It's About Time
Between Deterrence and Peace: What History Demands We Remember
Killing the 'Great Satan'
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement